Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.40 |
| ▸ | PPARG | P37231 | 7/20 | 0.40 |
| ▸ | PPARD | Q03181 | 7/20 | 0.40 |
| ▸ | PPARA | Q07869 | 7/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.40 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27579511 | 1.00 | L3MBTL1 (0.41) | L3MBTL1GPR84PPARGPPARDPPARA | |
| SCHEMBL10527700 | 1.00 | L3MBTL1 (0.41) | L3MBTL1GPR84PPARGPPARDPPARA | |
| SCHEMBL27628508 | 1.00 | L3MBTL1 (0.41) | L3MBTL1GPR84PPARGPPARDPPARA | |
| SCHEMBL10519536 | 1.00 | L3MBTL1 (0.41) | L3MBTL1GPR84PPARGPPARDPPARA | |
| SCHEMBL10484700 | 0.87 | FFAR3 (0.32) | L3MBTL1TDP1MEN1KMT2A | |
| Palmitic Acid SCHEMBL15659528 | 0.84 | GPR84 (0.49) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL28384679 | 0.82 | L3MBTL1 (0.46) | L3MBTL1GPR84PPARGPPARDPPARA | |
| SCHEMBL28142318 | 0.82 | L3MBTL1 (0.46) | L3MBTL1GPR84PPARGPPARDPPARA | |
| SCHEMBL16781375 | 0.76 | GNAI3 (0.33) | L3MBTL1TDP1MEN1KMT2A | |
| Palmitic Acid SCHEMBL1963468 | 0.74 | GPR84 (0.47) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616730-B2 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | MEDIHELPLINE CO., LTD (KR) | 2026-05-05 | — | — | US | disclosed |
| US-12465584-B2 | Agent for elevating nitric oxide concentration | KYOWA HAKKO BIO CO., LTD. (JP) | 2025-11-11 | — | — | US | disclosed |
| US-20250049664-A1 | SKIN EXTERNAL APPLICATION COMPOSITION FOR SKIN BARRIER STRENGTHENING OR SKIN MOISTURIZING CONTAINING DEHYDROABIETIC ACID | AMOREPACIFIC CORPORATION (KR) | 2025-02-13 | — | — | US | disclosed |
| EP-4074325-B1 | COMPOSITION FOR PREVENTING, INHIBITING OR TREATING INFECTION OF CORONAVIRUS | AMOREPACIFIC CORP (KR) | 2024-07-31 | — | — | EP | disclosed |
| US-20240156888-A1 | SKIN EXTERNAL COMPOSITION AND METHOD FOR PREPARING THE SAME | AMOREPACIFIC CORPORATION (KR) | 2024-05-16 | — | — | US | disclosed |
| CN-108697143-B | Moisturizing compositions comprising 3-O-galloyl-3,3', 5',7-pentahydroxyflavan | 株式会社爱茉莉太平洋 | 2023-09-12 | — | — | CN | disclosed |
| US-20230263761-A1 | AGENT FOR ELEVATING NITRIC OXIDE CONCENTRATION | KYOWA HAKKO BIO CO., LTD. (JP) | 2023-08-24 | — | — | US | disclosed |
| CN-110944644-B | Anti-inflammatory compositions comprising novel quercetin compounds | 株式会社爱茉莉太平洋 | 2023-06-13 | — | — | CN | disclosed |
| US-11666620-B2 | Method for treatment of fine dust-caused skin cell damage, reinforcement of skin barrier, anti-aging, and anti-inflammation | AMOREPACIFIC CORPORATION (KR) | 2023-06-06 | — | — | US | disclosed |
| US-11654125-B2 | Agent for elevating nitric oxide concentration | KYOWA HAKKO BIO CO., LTD. (JP) | 2023-05-23 | — | — | US | disclosed |
| WO-2006016728-A1 | COMPOSITION COMPRISING THE EXTRACT OF ACTINIDIA ARGUTA FOR PREVENTING AND TREATING BALDNESS DISORDERS AND SEBORRHEIC SKIN DISORDERS | HELIXIR CO., LTD. (KR) | 2006-02-16 | — | — | WO | disclosed |
| CN-1678333-A | Composition containing extract of actinidia arguta and related species for preventing and treating allergic diseases and non-allergic inflammatory diseases | PANGENOMICS CO LTD (KR) | 2005-10-05 | — | — | CN | disclosed |
| EP-1551433-A1 | COMPOSITION COMPRISING THE EXTRACT OF ACTINIDIA ARGUTA AND RELATED SPECIES FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE AND NON-ALLERGIC INFLAMMATORY DISEASE | Pangenomics Co., Ltd. (KR) | 2005-07-13 | — | — | EP | disclosed |
| CN-1197542-C | Cosmetics | KYOWA HAKKO KOGYO KK (JP) | 2005-04-20 | — | — | CN | disclosed |
| WO-2004096171-A1 | SKIN WHITENING COSMETIC COMPOSITION COMPRISING THE EXTRACT OF MACHILUS THUNBERGII AND THE COMPOUNDS ISOLATED THEREFROM | YEUNGNAM EDUCATIONAL FOUNDATION (KR) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004017982-A1 | COMPOSITION COMPRISING THE EXTRACT OF ACTINIDIA ARGUTA AND RELATED SPECIES FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE AND NON-ALLERGIC INFLAMMATORY DISEASE | PANGENOMICS CO., LTD (KR) | 2004-03-04 | — | — | WO | disclosed |
| US-6497889-B2 | CONTAINING HYDROXYPROLINE COMPOUND | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-12-24 | — | — | US | disclosed |
| US-20020009472-A1 | Cosmetics | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1166767-A2 | Skin care product containing hydroxyproline or N-acylated hydroxyproline derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-01-02 | — | — | EP | disclosed |
| CN-1328813-A | Cosmetics | KYOWA HAKKO KOGY CO LTD (JP) | 2002-01-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049664-A1 | SKIN EXTERNAL APPLICATION COMPOSITION FOR SKIN BARRIER STRENGTHENING OR SKIN MOISTURIZING CONTAINING DEHYDROABIETIC ACID | DSG1, PPARG, KRT18 | L3MBTL1 4386/4885GPR84 208/4885PPARG 2/4885 |
| US-12616730-B2 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | CUTA, VEGFA, MMP8 | L3MBTL1 967/4885GPR84 3533/4885PPARG 902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.